Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.3858
+0.0107 (2.85%)
At close: Aug 7, 2026, 4:00 PM EDT
0.3806
-0.0052 (-1.35%)
After-hours: Aug 7, 2026, 7:34 PM EDT

Immutep Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
4.130.060.120.190.250.31
Revenue Growth
6820.33%-49.86%-37.88%-24.63%-18.68%-95.97%
Gross Profit
4.130.060.120.190.250.31
Operating Income
-88.41-70-50.28-44.75-38.3-23.21
Net Income
-83.92-61.43-42.72-39.9-32.21-29.9
Earnings Per Share
-0.57-0.42-0.36-0.45-0.38-0.50
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Immunotherapy
7.915.033.843.514.713.86
Unallocated
-0.01----
Total
7.925.043.843.514.713.86

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
99.13129.69181.88123.428060.59
Total Debt
1.211.631.591.231.732.82
Net Cash (Debt)
97.92128.07180.28122.1978.2657.78
Net Cash Growth
-23.54%-28.96%47.54%56.13%35.45%234.55%
Net Cash Per Share
0.670.881.501.370.920.97

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-107.73-107.73-62.05-34.82-35.36-30.23
Capital Expenditures
-0.1-0.1-0.05-0.03-0.08-0.02
Free Cash Flow
-107.83-107.83-62.1-34.85-35.44-30.25
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-2139.63%-117227.00%-42220.70%-23338.80%-15054.70%-7417.84%
Pretax Margin
-2030.86%-102889.29%-35869.50%-20809.59%-12662.12%-9558.40%
Profit Margin
-2030.86%-102889.00%-35869.50%-20809.60%-12662.10%-9558.41%
FCF Margin
80.01%-103997.00%-29264.20%-18484.40%-11892.40%-5643.74%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
9.45-6099.613666.971961.161002.19